Dots and interconnected lines are superimposed over a crowd of people.

With in person scientific conferences back in full swing, COVID-19 still remains a risk.

credit: iStock/peterhowell

A conference and a COVID-19 close call

As scientific conferences return to in person programming, we still need COVID-19 precautions.
Stephanie DeMarco, PhD Headshot
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

As I pushed open the glass doors of the conference hall, I felt the familiar rush of excitement mixed with nerves unique to scientific conferences. People milled around the lobby, chatting with one another, poster tubes slung over their shoulders. Others hustled toward the escalators, laptops tucked under their arms. I slung my press pass over my neck and joined them, ready to soak up a week of exciting new science. But COVID-19 was never far from my mind.

While many people in my local community have stopped wearing masks inside, I’ve been slower to let my guard down. I have a close family member who is immunocompromised, and my family and I have spent these past three years of the pandemic being very careful to not get him sick.

Knowing that this conference would be the biggest COVID-19 risk I’d taken all pandemic, I did my best to prepare: I got the new bivalent COVID-19 booster and flu shot a couple of weeks before the meeting and restocked my stash of heavy duty KN95 masks.

Just as I’d hoped, the conference filled my cup with exciting new findings and experimental techniques that I can’t wait to share in DDN in the coming months. But the general lack of masking within the packed seminar rooms and poster hall surprised me. From my rough estimate, about a quarter of the attendees wore a face covering of some sort inside.

About three days after I returned home from the conference, my cellphone buzzed. An unfamiliar pink icon and a long block of text lit up my screen: California Department of Public Health - Possible exposure to COVID-19 virus. My heart sank.

As each rapid test and PCR test turned up negative, it seemed like I was spared. But a quick perusal of the conference hashtag on Twitter told me that other attendees were not so lucky.

Nothing can replace the organic interactions and joy of seeing old colleagues at in person scientific meetings. Some of the most fruitful collaborations and epiphanies happen at poster sessions or over coffee. But the risk of COVID-19 is still very real. Viruses don’t care about new conference friendships. They just want a new host to infect.

For many researchers who are immunocompromised or have family members who are, in person meetings are still inaccessible and will remain so for the foreseeable future. Even for healthy people, a mild COVID-19 infection can lead to long COVID and other long-term effects that scientists are still trying to understand.

There are many science backed precautions that conference organizers can impose to reduce the risk of COVID-19 among attendees. Requiring COVID-19 vaccination — which prevents severe disease but not necessarily infection — is a good start, but an indoor masking requirement is even better. Asking attendees to take a rapid antigen test before traveling to a conference is one simple precaution and having free or low cost testing available on site is another.

We will likely be living with COVID-19 for a long time, so how will we, as members of the scientific community, respond to it — with a shrug or with a plan?

About the Author

  • Stephanie DeMarco, PhD Headshot

    Stephanie joined Drug Discovery News as an Assistant Editor in 2021. She earned her PhD from the University of California Los Angeles in 2019 and has written for Discover Magazine, Quanta Magazine, and the Los Angeles Times. As an assistant editor at DDN, she writes about how microbes influence health to how art can change the brain. When not writing, Stephanie enjoys tap dancing and perfecting her pasta carbonara recipe.

Related Topics

Published In

March 2023 Magazine Front Cover
Volume 19 - Issue 3 | March 2023

March 2023

March 2023 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue